Ridgeback Capital Investments L.P. 13F Holdings · Q2 2026
Ridgeback Capital Investments L.P. reported 1 securities worth $80.93M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: REPL (100.00%), PYXS (0.00%). Among its top 25 positions this quarter: 1 new, 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | REPL | Replimune Group Inc. | $80.9M | 100.00% | 7.3M | New |
| 2 | PYXS | Pyxis Oncology Inc | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR